Companies · Ecommerce / Retail
San Francisco · CA, USA · Ecommerce / Retail · founded 2022 · https://soteriskin.com/
Diligence memoA one-page analyst read on SOTERI SKIN — recommendation, valuation, rhythm, risks.→SOTERI SKIN: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
SOTERI SKIN is one of 123 Ecommerce / Retail companies tracked from San Francisco, CA, USA, on record since 2022. By capital raised it ranks mid-pack (ahead of 57% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
D2C Skincare for Eczema
Soteri Skin is D2C skincare for chronic skin conditions like eczema. We’re the only non-prescription product proven to provide long-lasting relief for the 30 million Americans who suffer from eczema. How it works: Skin surface pH is constantly in flux, and many of your daily activities can throw it out of balance. People with chronic skin conditions such as eczema have a harder time regulating their skin's pH. Soteri's patented pH/LOCK™ locks skin in at a therapeutic pH for 12+ hours, which is shown to help break the cycle of skin sensitivity, whether you have eczema, psoriasis, or just a bad sunburn. Our formulations are aesthetically elegant (non-sticky, sit well under makeup, etc), safe for anyone to use, and don't require a prescription. Most people see skin health improvements within the first few weeks of application, even for tricky, chronic skin conditions like eczema and psoriasis. With Soteri Skin, anyone can enjoy healthy, glowing, pH-enomenal skin!
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
No staged rounds to sequence.
Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 123 companies in Ecommerce / Retail. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 57% of sector peers (real $). Modeled value above 57% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| No rounds recorded. | |||||
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
SOTERI SKIN is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Adla | Ecommerce / Retail | — | — | — | same sector |
| AfricaSokoni | Ecommerce / Retail | Pre-Seed | $995K | $7.8M | same sector |
| Afrikrea | Ecommerce / Retail | Pre-Seed | $1.0M | $7.8M | same sector |
| AgileBits Inc. | Ecommerce / Retail | Growth/Late | $883.9M | $160.9M | same sector |
| Aleph Solutions (Alephee) | Ecommerce / Retail | — | — | — | same sector |
| Algolia, Inc. | Ecommerce / Retail | Series D+ | $313.5M | $891.8M | same sector |
| AllSome Fulfillment | Ecommerce / Retail | — | — | — | same sector |
| Allure Systems | Ecommerce / Retail | — | — | — | same sector |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Northwind Tele-dermatology for chronic skin conditions | Healthtech | — | — | 71% |
| Skincure Oncology Llc | Pharma | Series B | $1.0B | 67% |
| Lygg Building New Anti-Aging Ingredients for Skincare | — | — | — | 67% |
| Soteria Biotherapeutics, Inc. | Biotechnology | Series B | $689.3M | 67% |
| Clinikally India's Telemedicine Platform & Online Pharmacy for Dermatology Care | Healthtech | — | — | 67% |
| SkinFix Inc. | Other | Series B | $245.8M | 67% |
| Digital Skincare Inc. | Software / Tech | Pre-Seed | $1.3M | 66% |
| ZO Skin Health, Inc. | Pharmaceuticals | Series A | $185.8M | 66% |
See where SOTERI SKIN sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at SOTERI SKIN, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.